Trials / Recruiting
RecruitingNCT06885905
Impact of Chronic Pulmonary Aspergillosis (CPA) on Health Status and Well-being
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
Conditions
Timeline
- Start date
- 2024-11-27
- Primary completion
- 2025-08-23
- Completion
- 2026-04-23
- First posted
- 2025-03-20
- Last updated
- 2025-03-20
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06885905. Inclusion in this directory is not an endorsement.